Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection [VISION]
Clinical trial NCT06216470 · RECRUITING
Trial details
- NCT number
- NCT06216470
- Sponsor
- University Health Network, Toronto
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-13
- Primary completion
- 2029-12-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.